IP Library Granted Patent US 10,760,045
Granted Patent B2
US 10,760,045 · App. 16/791,550 · Granted Sep 1, 2020

Cyanobacteria having improved photosynthetic activity

Inventors: James Roberts (Seattle, WA); Michael Carleton (Kirkland, WA); Damian Carrieri (Seattle, WA); Jason W. Hickman (San Diego, CA)
Assignee: LUMEN BIOSCIENCE, INC.
C12N1/20C07K14/195C12P7/64C12P7/649C12P7/6409C12P7/6436C12R1/89Y02E50/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,760,045
App. No.
16/791,550
Granted
Sep 1, 2020
Kind
B2
Abstract

This disclosure describes modified photosynthetic microorganisms, including Cyanobacteria, that have a reduced amount of a light harvesting protein (LHP) and contain one or more introduced or overexpressed polynucleotides encoding one or more enzymes associated with lipid biosynthesis, and which are capable of producing increased amounts of fatty acids and/or synthesizing triglycerides.

Claims (37)

1. A cell culture comprising a Cyanobacteria cell population, wherein the Cyanobacteria cell population comprises genetically modified Cyanobacteria cells that

1) are mutated to disrupt or delete one or more genes encoding one or more light harvesting proteins; and

2) comprise a nucleic acid sequence comprising an exogenous gene encoding an exogenous polypeptide, and wherein when the Cyanobacteria cell culture is cultured under light intensities between about

a) 200 micromol photons per square meter per second; and

b) about 1000 micromol photons per square meter per second, and

the genetically modified Cyanobacteria cell population expresses the exogenous polypeptide.

2. The cell culture of claim 1 , wherein the modified Cyanobacteria cell population comprises Cyanobacteria cells that are genetically modified to delete a phycobilisome gene.

3. The cell culture of claim 2 , wherein the phycobilisome gene is a phycobiliprotein gene.

4. The cell culture of claim 3 , wherein the phycobiliprotein gene is a phycocyanin gene.

5. The cell culture of claim 1 , wherein the modified Cyanobacteria cell comprises addition of an endogenous NbIA gene.

6. The cell culture of claim 1 , wherein the exogenous polypeptide is a therapeutic polypeptide.

7. The cell culture of claim 1 , wherein the Cyanobacteria cell population has

1) an increased biomass; and

2) an increased level of photosynthetic activity

as compared to a corresponding unmodified Cyanobacteria cell population.

8. The cell culture of claim 1 , wherein the nucleic acid sequence comprising an exogenous gene encoding an exogenous polypeptide is present on a vector.

9. The cell culture of claim 1 , wherein the nucleic acid sequence comprising an exogenous gene encoding an exogenous polypeptide is integrated into the Spirulina genome.

10. A method of producing an exogenous polypeptide in a Cyanobacteria culture comprising:

1) providing a modified Cyanobacteria cell population that comprises genetically modified Cyanobacteria cells that

a) are mutated to disrupt or delete one or more genes encoding one or more light harvesting proteins; and

b) comprise a nucleic acid sequence comprising an exogenous gene encoding an exogenous polypeptide;

2) growing the modified Cyanobacteria cell population wherein when the Cyanobacteria cell culture is cultured under light intensities between about

a) 200 micromol photons per square meter per second; and

b) about 1000 micromol photons per square meter per second;

growing the modified Cyanobacteria cell population to obtain a Cyanobacteria culture; and,

wherein the genetically modified Cyanobacteria cell population expresses the exogenous polypeptide.

11. The method of claim 1 , wherein the modified Cyanobacteria cell population comprises Cyanobacteria cells that are genetically modified to delete a phycobilisome gene.

12. The method of claim 11 , wherein the phycobilisome gene is a phycobiliprotein gene.

13. The method of claim 12 wherein the phycobiliprotein gene is a phycocyanin gene.

14. The method of claim 1 , wherein the modified Cyanobacteria cell comprises addition of an endogenous NbIA gene.

15. The method of claim 1 , wherein the exogenous polypeptide is a therapeutic polypeptide.

16. The method of claim 1 , wherein the Cyanobacteria cell population has

1) an increased biomass; and

2) an increased level of photosynthetic activity

as compared to a corresponding unmodified Cyanobacteria cell population.

17. The method of claim 1 wherein the nucleic acid sequence comprising an exogenous gene encoding an exogenous polypeptide is present on a vector.

18. The method of claim 1 , wherein the nucleic acid sequence comprising an exogenous gene encoding an exogenous polypeptide is integrated into the Spirulina genome.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2020
From: ROBERTS, JAMES; HICKMAN, JASON W.; CARLETON, MICHAEL; CARRIERI, DAMIAN
To: MATRIX GENETICS, LLC
Reel/Frame 052375/0032 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 13, 2020
From: MATRIX GENETICS, LLC
To: LUMEN BIOSCIENCE, INC.
Reel/Frame 052375/0042 →
Continuity (4)
Continuation 15879993 · Jan 25, 2018
Continuation 14775606
Provisional Application 61780755 · Mar 13, 2013
Related Publication 20200172859A1 · Jun 4, 2020
Cited By (3)
US 12,252,513 US 12,447,202 US 12,503,682